We are live on ! Find out more
BIOL

Biolase, Inc.
BIOL

Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

36 hedge funds and large institutions have $30.4M invested in Biolase, Inc. in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 1

56% more capital invested

Capital invested by funds: $19.5M → $30.4M (+$10.9M)

20% more funds holding

Funds holding: 30 → 36 (+6)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
36
Holders Change
+6
Holders Change %
+20%
% of All Funds
0.96%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
7
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$151K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$37.6K
3
VKH
Virtu KCG Holdings
New York
+$37.6K
4
Citadel Advisors
Citadel Advisors
Florida
+$25.1K
5
GC
Guggenheim Capital
Illinois
+$12.5K

Top Sellers

Rank Fund Capital Flow
1
PCMI
Princeton Capital Management Inc
New Jersey
-$37.6K
2
BFA
BlackRock Fund Advisors
California
-$12.5K
3
IA
IFP Advisors
Florida
-$11K
4
AIG
American International Group
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
26
T. Rowe Price Associates
Maryland
$23K – – –
Nomura Holdings
27
Nomura Holdings
Japan
$19K +$12.5K +1 New
GC
28
Guggenheim Capital
Illinois
$17K +$12.5K +1 New
Commonwealth Equity Services
29
Commonwealth Equity Services
Massachusetts
$16K – – –
BA
30
BlackRock Advisors
Delaware
$15K – – –
LPL Financial
31
LPL Financial
California
$15K +$12.5K +1 New
TSS
32
Two Sigma Securities
New York
$15K +$12.5K +1 New
WS
33
Wedbush Securities
California
$14K – – –
UBS Group
34
UBS Group
Switzerland
$12K – – –
BIM
35
BlackRock Investment Management
Delaware
$11K – – –
Bank of America
36
Bank of America
North Carolina
$4K – – –
TRCT
37
Tower Research Capital (TRC)
New York
$3K – – –
CG
38
Cutler Group
California
$2K – – –
Manulife (Manufacturers Life Insurance)
39
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K – – –
BC
40
Barnett & Company
Tennessee
$1K – – –
Citigroup
41
Citigroup
New York
$1K – – –
JFA
42
JNBA Financial Advisors
Minnesota
$1K – – –
KF
43
Krilogy Financial
Missouri
$1K – – –
LTFS
44
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Geode Capital Management
45
Geode Capital Management
Massachusetts
$255 – – –
IA
46
IFP Advisors
Florida
– -$11K -1 Closed
AIG
47
American International Group
New York
– -$1K – –
1
2

BIOL Hedge Fund Activity: Q1 2016 in Review

36 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q1 2016, worth a combined $30.4M — up 56% from $19.5M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new BIOL positions and 1 closed out — a net gain of 6 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Consonance Capital Management, adding an estimated $151K. The largest seller was Princeton Capital Management Inc, cutting an estimated $37.6K.

  • 36 institutional investors held Biolase, Inc. (BIOL) as of Q1 2016, up from 30 in Q4 2015.
  • Funds reported $30.4M of Biolase, Inc. stock for Q1 2016, up 56% quarter-over-quarter.
  • 7 funds opened new Biolase, Inc. positions in Q1 2016 and 1 closed out, a net change of +6 holders.
  • The largest Biolase, Inc. buyer in Q1 2016 was Consonance Capital Management, an estimated $151K added.
  • The largest Biolase, Inc. seller in Q1 2016 was Princeton Capital Management Inc, an estimated $37.6K sold.

Based on aggregated 13F filings for Q1 2016.